Adam P Bress
Works at
Associate professor
Sources: reporter.nih.gov
Grants and prizes
R01, Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarker Trajectories by AD Pathology: Elucidating neuroprotective effects in the SPRINT trial, R01AG096179, 2025–2030, 27 Jul 2026
R01, Real-world evidence to clarify risk-benefit of antihypertensive intensification vs. de-escalation and blood pressure thresholds to minimize harms and maximize brain and heart health in older adults, R01AG097580, 2026–2031, 17 Jul 2026
K24, Using pharmacoepidemiology to optimize antihypertensive medication use to prevent aging-related multimorbidity: Midcareer investigator award in patient-oriented research and mentoring., K24AG080168, 2023–2028, 17 Feb 2026
R01, Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of life, R01AG074989, 2022–2026, 25 Aug 2025
R01, Guiding next steps for SPRINT-MIND implementation: Identifying high-benefit subgroups and comparative effects of ARB- vs. ACEI-based regimens, R01AG065805, 2020–2026, 19 Apr 2023
Sources: reporter.nih.gov